Roger Waltzman
Directeur Technique/Scientifique/R&D chez INDAPTUS THERAPEUTICS, INC.
Postes actifs de Roger Waltzman
Sociétés | Poste | Début | Fin |
---|---|---|---|
INDAPTUS THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 07/08/2023 | - |
Historique de carrière de Roger Waltzman
Anciens postes connus de Roger Waltzman
Sociétés | Poste | Début | Fin |
---|---|---|---|
MOLECULAR TEMPLATES, INC. | Directeur Technique/Scientifique/R&D | 19/02/2019 | 01/08/2023 |
Jaguar Animal Health, Inc.
Jaguar Animal Health, Inc. Pharmaceuticals: MajorHealth Technology Jaguar Animal Health, Inc. engages in the development and commercialization of gastrointestinal products for companion and production animals. Its product, Canalevia, is the company's prescription drug product candidate for the treatment of various forms diarrhea in dogs. It also developed its non-prescription product, Neonorm Calf, which helps dairies and beef farms proactively retain fluid in calves. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA. | Directeur Technique/Scientifique/R&D | 30/06/2016 | 03/04/2017 |
JAGUAR HEALTH, INC. | Directeur Technique/Scientifique/R&D | 01/07/2016 | 03/04/2017 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01/01/2013 | 01/01/2016 |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | Directeur Technique/Scientifique/R&D | - | - |
Napo Pharmaceuticals, Inc.
Napo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Napo Pharmaceuticals, Inc. provides pharmaceutical products for gastro-intestinal disorders. The company was founded by Lisa A. Conte in November 2001 and is headquartered in San Francisco, CA. | Directeur Technique/Scientifique/R&D | - | - |
President | - | - |
Formation de Roger Waltzman
Columbia Business School | Masters Business Admin |
Brown University | Undergraduate Degree |
The Warren Alpert Medical School | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 11 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 6 |
Masters Business Admin | 1 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 8 |
Consumer Services | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
JAGUAR HEALTH, INC. | Health Technology |
MOLECULAR TEMPLATES, INC. | Health Technology |
INDAPTUS THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 4 |
---|---|
Jaguar Animal Health, Inc.
Jaguar Animal Health, Inc. Pharmaceuticals: MajorHealth Technology Jaguar Animal Health, Inc. engages in the development and commercialization of gastrointestinal products for companion and production animals. Its product, Canalevia, is the company's prescription drug product candidate for the treatment of various forms diarrhea in dogs. It also developed its non-prescription product, Neonorm Calf, which helps dairies and beef farms proactively retain fluid in calves. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA. | Health Technology |
Napo Pharmaceuticals, Inc.
Napo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Napo Pharmaceuticals, Inc. provides pharmaceutical products for gastro-intestinal disorders. The company was founded by Lisa A. Conte in November 2001 and is headquartered in San Francisco, CA. | Health Technology |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
- Bourse
- Insiders
- Roger Waltzman
- Expérience